Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Mouth Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Tongue Neoplasms 1 Solid Tumor 1 Skin Lesion 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Postoperative Complications 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Pancreatic Neoplasms 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Liver Neoplasms 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Cysts 1 Cholecystitis 1 Brain Neoplasms 1 Arachnodactyly 1 Abortion, Spontaneous 1

Interventions

Radiosurgery 50 Magnetic Resonance Spectroscopy 34 Temozolomide 28 Bevacizumab 24 pembrolizumab 23 Radiotherapy 20 Nivolumab 20 Specimen Handling 14 Ipilimumab 13 Cyclophosphamide 13 Mental Status and Dementia Tests 12 Carboplatin 12 abemaciclib 10 Radiation 10 trastuzumab deruxtecan 8 Proton Therapy 7 Pemetrexed 7 Memantine 7 Blood Specimen Collection 7 fluciclovine F-18 6 binimetinib 6 Paclitaxel 6 Lomustine 6 Etoposide 6 Cisplatin 6 Capecitabine 6 encorafenib 5 Trastuzumab 5 Surveys and Questionnaires 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Ultrasonography × 1 year × Clear all

NCT02656407 2025-09-02

FUSIMAGINE

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡